Symptoms: possible pain in the stomach, vomiting, diarrhea.
Treatment: symptomatic.
hypersensitivity to the components of the drug, including primrose and thyme, as well as other plants of the genus primrose and / or the family lipotsvetnye,
gastrointestinal diseases in the acute stage,
lactose intolerance, lactase deficiency, glucose-galactose malabsorption (the content of lactose monohydrate and glucose in the preparation),
children under 12 years of age, due to the lack of clinical data.
Bronchipret tablets® TP should not be used simultaneously with antitussive drugs, as well as with drugs that reduce the formation of sputum, because this makes it difficult to cough up liquefied sputum.
Possible combination with antibacterial drugs.
Pills: round, biconvex shape, green color with a semi-matt surface, covered with a film shell..
Allergic reactions, due to hypersensitivity to the components of the drug, for example, shortness of breath, skin rashes, urticaria, swelling of the face, mouth and/or pharynx. If the first signs of an allergic reaction appear, stop taking the drug and seek medical advice.
From the gastrointestinal tract: rarely — nausea, vomiting, diarrhea, spastic pain.
Without a prescription.
If the drug is used for 7 days, the symptoms of the disease persist or the patient's condition worsens, you should consult a doctor.
The drug can be prescribed to patients with diabetes mellitus, because 1 table., pp. o. contains less than 0.03 XE.
Influence on the ability to drive vehicles and work with mechanisms. When used in the recommended doses, the drug does not affect the ability to drive vehicles and mechanisms.
As an expectorant in the treatment of acute and chronic inflammatory diseases of the respiratory tract, accompanied by cough and sputum formation (tracheitis, tracheobronchitis, bronchitis).
The drug has an expectorant, anti-inflammatory, secretolytic, bronchodilator effect, helps to reduce the viscosity of sputum and accelerate its evacuation.
At a temperature not exceeding 25 °C, in the original packaging.
Keep out of reach of children.
Expiration date of the drug Bronchipret® TP3 года.Do not use after the expiration date indicated on the package.
| Film-coated tablets | 1 table. |
| active ingredients: | |
| primrose root extract dry (6-7:1) | 60 mg |
| (extractant-ethanol 47.4 vol.%) | |
| thyme herb extract dry (6-10:1) | 160 mg |
| (extractant — ethanol 70.%) | |
| excipients: lactose monohydrate, glucose, povidone K25, crospovidone, colloidal anhydrous silicon dioxide, MCC, magnesium stearate | |
| the shell film: titanium dioxide (E171), talc, chlorophyll powder (E141), riboflavin (E101), propylene glycol, hypromellose, polyacrylate dispersion 30% (dry substance), dimethicone, peppermint flavor, sodium saccharinate |
Film-coated tablets. In blisters of PVC/PVDC films and aluminum foils of 20 or 25 pieces each. 1 (20 pcs.), 2 (25 pcs.), 4 (25 pcs.) or 5 (20 pcs.) bl. in a pack of cardboard.
It should not be used during pregnancy and lactation.
Inside, swallow without chewing, with a small amount of water.
Adults and children over 12 years of age: 1 tablet 3 times a day before meals. The average course of treatment is 10-14 days. Increasing the duration and conducting repeated courses of treatment is possible on the recommendation of a doctor.
R05CA Expectorant drugs
